Further characterization of amyloid-enhancing factor

Area of Science:

• Biochemistry
• Immunology
• Pathology

Background:

• Amyloid deposition is a hallmark of various diseases.
• Amyloid-enhancing factor (AEF) is a known accelerator of amyloid formation.
• Understanding AEF's properties is crucial for developing therapeutic strategies.

Purpose of the Study:

• To characterize the properties and behavior of Amyloid-enhancing factor (AEF).
• To investigate the induction and localization of AEF.
• To determine the molecular characteristics of the active AEF component.

Main Methods:

• Induction of AEF in CBA/J mice using azocasein or silver nitrate.
• Intravenous administration of AEF and assessment of splenic amyloid deposition.
• Subcellular fractionation of liver tissue to identify AEF-containing organelles.
• Solubilization in 4 M glycerol and Sepharose 4B chromatography.
• Disc electrophoresis for tentative identification of the active component.

Main Results:

• AEF significantly reduced splenic amyloid deposition induction time to 48 hours.
• Azocasein or silver nitrate induced AEF in spleen and liver, with activity found in liver subcellular organelles.
• Intravenous AEF administration localized to spleen perifollicular areas and liver Kupffer cells.
• AEF activity persisted for at least 4 weeks.
• AEF was solubilized in 4 M glycerol, was high molecular weight, and distinct from amyloid A protein and serum amyloid P component.

Conclusions:

• AEF is a transferable factor that accelerates amyloid deposition.
• AEF possesses adherent properties and specific tissue localization.
• The active component of AEF is a high molecular weight entity, not amyloid A or SAP.